Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

61.19
+0.69001.14%
Post-market: 60.80-0.3900-0.64%16:21 EDT
Volume:893.69K
Turnover:54.84M
Market Cap:5.83B
PE:24.76
High:61.72
Open:60.76
Low:60.75
Close:60.50
52wk High:83.25
52wk Low:60.14
Shares:95.25M
Float Shares:60.41M
Volume Ratio:1.44
T/O Rate:1.48%
Dividend:1.38
Dividend Rate:2.26%
EPS(TTM):2.47
EPS(LYR):2.62
ROE:9.46%
ROA:5.27%
PB:2.25
PE(LYR):23.35

Loading ...

Strategic Advancements and Growth Potential Drive Buy Rating for Dolby Laboratories

TIPRANKS
·
Nov 19, 2025

BUZZ-Dolby down after holiday-quarter forecast misses estimates

Reuters
·
Nov 19, 2025

Rosenblatt Securities Reaffirms Their Buy Rating on Dolby Laboratories (DLB)

TIPRANKS
·
Nov 19, 2025

Dolby Laboratories Reports Strong Q4 2025 Financial Results

TIPRANKS
·
Nov 19, 2025

BRIEF-Dolby Laboratories Q4 Revenue USD 307 Million Vs. IBES Estimate USD 304.7 Million

Reuters
·
Nov 19, 2025

Dolby Laboratories Reports $307 Million Revenue for Fourth Quarter 2025

Reuters
·
Nov 19, 2025

Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results

THOMSON REUTERS
·
Nov 19, 2025

Dolby Laboratories Outlook Q1 EPS USD 0.39-0.54

THOMSON REUTERS
·
Nov 19, 2025

Dolby Laboratories Inc: Outlook FY Adj EPS $4.19 to $4.34

THOMSON REUTERS
·
Nov 19, 2025

Dolby Laboratories Q4 Revenue USD 307 Million VS. Ibes Estimate USD 304.7 Million

THOMSON REUTERS
·
Nov 19, 2025

Top News Today: Stocks Slide on AI Doubts

Dow Jones
·
Nov 18, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 17, 2025

Dolby Unveils 2026 Executive Bonus Plan Tied to Performance Targets

Reuters
·
Nov 15, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 14, 2025

Press Release: CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Dow Jones
·
Nov 10, 2025

Press Release: Cognition Therapeutics Reports Financial Results for the Third Quarter 2025 and Highlights Progress Across Clinical Programs

Dow Jones
·
Nov 06, 2025

CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies

GlobeNewswire
·
Nov 04, 2025

Press Release: CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley

Dow Jones
·
Oct 28, 2025

Dolby Laboratories Inc to announce fourth quarter and full year fiscal 2025 financial results

Reuters
·
Oct 09, 2025

Press Release: CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer

Dow Jones
·
Oct 07, 2025